Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Bavarian Nordic — September 2017

Planlagt Fastgjort Låst Flyttet Bavarian Nordic
357 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    GeorgeBest
    wrote on sidst redigeret af
    #41

    Disse data ser meget fine ud, med mindre placebo-gruppen denne gang har performet væsentlig bedre end ved tidligere studier.

    1 Reply Last reply
    0
    • G Offline
      G Offline
      GeorgeBest
      wrote on sidst redigeret af
      #42

      Og det kan man desværre ikke udelukke. Men er det sandsynligt?

      1 Reply Last reply
      0
      • D Offline
        D Offline
        Doc4
        wrote on sidst redigeret af
        #43

        Mit første input til et super forum:)

        1 Reply Last reply
        0
        • D Offline
          D Offline
          Doc4
          wrote on sidst redigeret af
          #44

          Based on patients’ ratings of their pain, the effect of trialled drugs in relieving symptoms stayed the same over the 23-year period—but placebo responses rose. In 1996, patients in clinical trials reported that drugs relieved their pain by 27% more than did a placebo. But by 2013, that gap had slipped to just 9%. The phenomenon is driven by 35 US trials; among trials in Europe, Asia and elsewhere, there was no significant change in placebo reponses.The analysis is in press in the journal Pain.

          1 Reply Last reply
          0
          • D Offline
            D Offline
            Doc4
            wrote on sidst redigeret af
            #45

            ...fra Scientific American

            1 Reply Last reply
            0
            • K Offline
              K Offline
              Kurt_Thyring
              wrote on sidst redigeret af
              #46

              Novod siger spændende data -

              1 Reply Last reply
              0
              • B Offline
                B Offline
                BiotechPro
                wrote on sidst redigeret af
                #47

                Nordea: So unless the placebo/control group ends up performing vastlydifferently than in recent trials with Xtandi and Ipilimumab, OS could be significantly increased with PROSTVAC. We are cautious in drawing too firm conclusions, but we find Dr Gulley’s presentation intriguing ahead of the final PROSTVAC ph III read-out.

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  Kurt_Thyring
                  wrote on sidst redigeret af
                  #48

                  Dette må være et godt tegn, så vi kan sove roligere indtil de endelige resultater. Ingen markant reaktion på markedet. Shorterne må da blive lidt bekymrede over di
                  sse data

                  1 Reply Last reply
                  0
                  • N Offline
                    N Offline
                    nik_hs1990
                    wrote on sidst redigeret af
                    #49

                    Facebook

                    favicon

                    (www.facebook.com)

                    1 Reply Last reply
                    0
                    • N Offline
                      N Offline
                      nik_hs1990
                      wrote on sidst redigeret af
                      #50

                      Vel ikke overrakskende at der er et fald i receptudskrivelserne i industriferien?

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        jkj
                        wrote on sidst redigeret af
                        #51

                        nej

                        1 Reply Last reply
                        0
                        • N Offline
                          N Offline
                          nik_hs1990
                          wrote on sidst redigeret af
                          #52

                          godt. Så er vi enige.

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bb
                            wrote on sidst redigeret af
                            #53

                            BAVA: http://www.bavarian-nordic.com/media/261385/170911-gulley-en.pdf

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bikube
                              wrote on sidst redigeret af
                              #54

                              Den fik vi kl. 10.21 fra jkj.

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bb
                                wrote on sidst redigeret af
                                #55

                                Ok - h
                                avde jeg ikke set.

                                1 Reply Last reply
                                0
                                • K Offline
                                  K Offline
                                  Kurt_Thyring
                                  wrote on sidst redigeret af
                                  #56

                                  bemaerk at den samlede overlevelseskurve er stort set vandret fra måned 50 til 65. Der er jo - som tidligere fortalt - stort set ingen der doer. Ca 23-24 % synes at leve sygdommen. Fortsaetter denne udvikling vil det blive rigtig stort.

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    GeorgeBest
                                    wrote on sidst redigeret af
                                    #57

                                    Kurt - pas på med at blive for optimistisk. Tænk på at standardbehandlingen har forbedrets markant siden Xtandis godkendelse. Så placebogruppen klarer sig derfor også bedre end tidligere. Jeg vil bare mane til lidt forsigtighed!

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #58

                                      Vi har jo netop i dag et eksempel af den slags med Livitag fra Onxeo:

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #59

                                        https://www.onxeo.com/onxeo-announces-top-line-results-relive-phase-iii-study-livatag-advanced-hepatocellular-carcinoma/

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #60

                                          Enig Sukker.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger